Stocks and Investing
Stocks and Investing
Thu, July 13, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kevin Caliendo Maintained (ALHC) at Hold with Decreased Target to $6 on, Jul 13th, 2023
Published on 2024-10-28 04:48:09 - WOPRAI, Kevin Caliendo
Kevin Caliendo of UBS, Maintained "Alignment Healthcare, Inc." (ALHC) at Hold with Decreased Target from $8 to $6 on, Jul 13th, 2023.
Kevin has made no other calls on ALHC in the last 4 months.
There are 3 other peers that have a rating on ALHC. Out of the 3 peers that are also analyzing ALHC, 1 agrees with Kevin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Lisa Gill of "JP Morgan" Maintained at Hold with Decreased Target to $10 on, Friday, July 7th, 2023
These are the ratings of the 2 analyists that currently disagree with Kevin
- John Ransom of "Raymond James" Upgraded from Hold to Buy and Held Target at $9 on, Monday, May 1st, 2023
- Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $12 on, Wednesday, April 19th, 2023
Contributing Sources